Bioceres Crop Solutions Corp. filings document a foreign private issuer reporting through Form 6-K as a Form 20-F filer, with interim results, press releases and XBRL-tagged financial data prepared under IFRS. The disclosures cover revenue and margin trends by crop protection, seed and integrated products, and crop nutrition, along with currency risk, property and equipment, debt securities, bank borrowings, subsidiaries, joint ventures and associates.
The filing record also includes annual general meeting proxy materials, Nasdaq minimum bid-price correspondence, and material-event reports involving convertible and non-convertible note purchase agreements, acceleration notices, collateral matters and Pro Farm-related proceedings. Certain Form 6-K reports are incorporated by reference into Form F-3 and Form S-8 registration statements, linking current reports to the company's securities registration disclosures.
BAF Latam Credit Fund B.V. reports beneficial ownership of 3,461,430 ordinary shares of Bioceres Crop Solutions Corp. (BIOX), representing 5.52% of the class based on the issuer's reported outstanding share count of 62,712,602. The filing states BAF holds sole voting power and sole dispositive power over the disclosed shares.
The statement was submitted on Schedule 13G and includes an Item 10 certification that the securities were not acquired to change or influence control of the issuer, indicating the filer describes the position as passive under the Schedule 13G framework.
Jasper Lake Ventures One LLC and Noah Kolatch report a combined economic interest of 7,382,919 ordinary shares in Bioceres Crop Solutions Corp. (BIOX), representing approximately 10.6% of the outstanding class on the calculation in this filing. That position includes 397,000 Ordinary Shares held directly by Jasper Lake plus the Ordinary Shares issuable upon conversion of a secured guaranteed convertible Note into 6,985,919 Ordinary Shares as of this filing.
The Notes were purchased under a Note Purchase Agreement as part of a $55,000,000 issuance, with Jasper Lake acquiring $33,500,000 in principal. The Notes bore regular interest at 9.00% per year until June 15, 2025 and 15.00% thereafter, mature on August 31, 2027, and are convertible into Ordinary Shares using a Strike Price originally equal to $6.00 subject to customary anti-dilution adjustments and price-based reductions in certain financings. PIK interest accrues and compounds, increasing the Accreted Principal Amount and the number of shares issuable on conversion.
Under an amendment, Noah Kolatch was appointed to the Issuer's Board and the Issuer also appointed Scott Croco and Milen Marinov; replacement-nomination rights for certain directors are described. The Reporting Persons state the acquisition was for investment purposes, note registration rights were granted, and disclose they may engage with management or consider actions including acquiring or disposing of securities, hedging, or proposing strategic alternatives.
Bioceres Group Limited and affiliates trimmed their stake in Bioceres Crop Solutions Corp. (BIOX) in Schedule 13D/A Amendment No. 15 dated 08 Aug 2025. The group’s beneficial ownership fell to 15,497,402 ordinary shares, equal to 24.7 % of BIOX’s 62,848,483 shares outstanding, down from 18,561,323 shares previously reported. The reduction—≈ 6.14 million shares—resulted from open-market sales and enforcement of pledge agreements executed under the New York UCC to satisfy financial obligations.
Breakdown of holdings: Bioceres Group Limited holds 70,785 shares directly and, through subsidiaries, shares voting/dispositive power over 15.4 million. Subsidiaries Bioceres LLC and THEO I SCSp own 14,989,117 (23.8 %) and 437,500 (0.7 %) shares, respectively. Of the total, 3,076,079 shares are subject to a 2019 Shareholders Agreement giving the group shared voting rights.
Key takeaways for investors: (1) Bioceres entities remain BIOX’s largest shareholder but have reduced influence by ~4.8 percentage points; (2) Sale was motivated by obligation settlement, not stated strategic change; (3) No new plans or proposals affecting BIOX were disclosed.
The excerpt provided for Bioceres Crop Solutions Corp.’s 6-K filing consists almost entirely of internal XBRL element names (e.g., biox:PublicCorporateBondsMember, ifrs-full:ParentMember) and date delimiters. It contains no narrative disclosure, financial metrics, transaction descriptions, or explanatory notes. Because the submission lacks quantitative data or management commentary, there is insufficient publicly disclosed information to determine the nature, magnitude, or timing of any “major transactions” referenced in the metadata.
Without contextual narrative or figures, investors and analysts cannot assess material impacts on revenue, earnings, cash flow, leverage, or strategic positioning. As such, no meaningful financial analysis can be produced from the content supplied.